Jpmorgan Chase & CO Aura Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

$1.23 Trillion
Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 94,386 shares of AURA stock, worth $685,242. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,386

Previous 53,502 76.42%

Holding current value

$685,242

Previous $476,000 62.82%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$8.11 - $11.74 $331,569 - $479,978	40,884 Added 76.42%	94,386 $775,000
Q3 2024 Dec 26, 2024	BUY	$6.9 - $10.36 $191,254 - $287,158	27,718 Added 107.5%	53,502 $476,000
Q3 2024 Nov 08, 2024	BUY	$6.9 - $10.36 $191,254 - $287,158	27,718 Added 107.5%	53,502 $476,000
Q2 2024 Dec 26, 2024	SELL	$6.81 - $7.89 $188,759 - $218,695	-27,718 Reduced 51.81%	25,784 $194,000
Q2 2024 Aug 12, 2024	BUY	$6.81 - $7.89 $10,208 - $11,827	1,499 Added 6.17%	25,784 $194,000
Q1 2024 Dec 26, 2024	SELL	$7.09 - $9.24 $207,148 - $269,965	-29,217 Reduced 54.61%	24,285 $190,000
Q1 2024 May 10, 2024	BUY	$7.09 - $9.24 $42,008 - $54,747	5,925 Added 32.27%	24,285 $190,000
Q4 2023 Dec 26, 2024	SELL	$7.02 - $11.98 $246,696 - $421,001	-35,142 Reduced 65.68%	18,360 $162,000
Q4 2023 Feb 12, 2024	SELL	$7.02 - $11.98 $1,972 - $3,366	-281 Reduced 1.51%	18,360 $162,000
Q3 2023 Nov 14, 2023	SELL	$8.97 - $12.38 $27,179 - $37,511	-3,030 Reduced 13.98%	18,641 $167,000
Q2 2023 Aug 11, 2023	BUY	$8.51 - $13.33 $27,002 - $42,296	3,173 Added 17.15%	21,671 $267,000
Q1 2023 May 18, 2023	BUY	$8.88 - $12.11 $160,905 - $219,433	18,120 Added 4793.65%	18,498 $171,000
Q1 2023 May 11, 2023	SELL	$8.88 - $12.11 $92,067 - $125,556	-10,368 Reduced 96.48%	378 $3,000
Q4 2022 Feb 13, 2023	BUY	$9.86 - $14.59 $7,227 - $10,694	733 Added 7.32%	10,746 $113,000
Q3 2022 Nov 14, 2022	BUY	$13.1 - $20.34 $2,816 - $4,373	215 Added 2.19%	10,013 $181,000
Q2 2022 Aug 11, 2022	BUY	$12.37 - $21.86 $88,692 - $156,736	7,170 Added 272.83%	9,798 $139,000
Q1 2022 May 11, 2022	SELL	$15.94 - $23.34 $63,233 - $92,589	-3,967 Reduced 60.15%	2,628 $58,000
Q4 2021 Feb 10, 2022	BUY	$14.76 - $24.89 $97,342 - $164,149	6,595 New	6,595 $112,000

Others Institutions Holding AURA

# of Institutions

Shares Held

39.9M

Call Options Held

1.9K

Put Options Held

31K

View Full List

About Aura Biosciences, Inc.

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $213M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

More about AURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Aura Biosciences, Inc. Transaction History